Overview
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
Source
Originally published at www.aljazeera.com.
Politics
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
Key Takeaway
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
Frequently Asked Questions
What is "Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread" about?+
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
Who reported this story?+
This story was reported by Al Jazeera.